2020
DOI: 10.1016/j.jcyt.2020.04.091
|View full text |Cite
|
Sign up to set email alerts
|

Cryopreserved bone marrow aspirate concentrate as a cell source for the colony-forming unit fibroblast assay

Abstract: The prevalence of connective tissue progenitor cells within a cell-based therapy is often quantified using the colony-forming unit fibroblast (CFU-F) assay. The present study investigates the feasibility of using cryopreserved bone marrow aspirate concentrate (BMAC) as an alternative cell source to fresh BMAC for CFU-F quantification. Methods: Freshly prepared and corresponding cryopreserved BMAC samples from patients receiving autologous cell therapy (n = 98) were analyzed using the CFU-F assay for comparison… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(16 citation statements)
references
References 42 publications
1
15
0
Order By: Relevance
“…It should be noted that while we used culture conditions that have reliably generated CFU-Fs from bone marrow, the lack of CFU-Fs does not preclude the existence of stem cells within UC allograft products, as laboratory variables–including choice of basal media, growth factors or other culture supplements, and plating density, and environmental conditions, such as oxygen levels–can affect colony formation. 1 Despite these variables, the present study reached similar conclusions to previously analyzed amniotic fluid allograft products; all UC allograft products failed to form CFU-Fs using conventional methods, contradicting claims that these are stem cell therapies. 26 On the other hand, BMC from middle-aged patients undergoing routine orthobiologic procedures consistently produces CFU-Fs, with frequencies ranging from tens to hundreds of colonies per million cells plated.…”
Section: Discussionsupporting
confidence: 74%
See 2 more Smart Citations
“…It should be noted that while we used culture conditions that have reliably generated CFU-Fs from bone marrow, the lack of CFU-Fs does not preclude the existence of stem cells within UC allograft products, as laboratory variables–including choice of basal media, growth factors or other culture supplements, and plating density, and environmental conditions, such as oxygen levels–can affect colony formation. 1 Despite these variables, the present study reached similar conclusions to previously analyzed amniotic fluid allograft products; all UC allograft products failed to form CFU-Fs using conventional methods, contradicting claims that these are stem cell therapies. 26 On the other hand, BMC from middle-aged patients undergoing routine orthobiologic procedures consistently produces CFU-Fs, with frequencies ranging from tens to hundreds of colonies per million cells plated.…”
Section: Discussionsupporting
confidence: 74%
“…26 On the other hand, BMC from middle-aged patients undergoing routine orthobiologic procedures consistently produces CFU-Fs, with frequencies ranging from tens to hundreds of colonies per million cells plated. 1…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…MSCs are spindle-shaped and adherent cells, capable of proliferation, self-renewal, and differentiating into cells of multi-lineage. One of the characteristic features of MSCs is adhering to tissue culture plastic and generating colonies when plated at low densities [ 78 ]. MSCs growing from individual foci, or colonies from the microscopic view, and these colonies generated from progenitor cells have been called the colony-forming unit fibroblast [ 79 ].…”
Section: Mscs and Mscs-exosomes: Cell Selection And Preparationmentioning
confidence: 99%
“…Please see our prior publication for a detailed description of the bone marrow aspiration and concentration protocol. 20,45 This isolation produced 2-5 mL of BMC, which was sterilely transported from the clinic-based laboratory to the clinic procedural suite. A total nucleated cell (TNC) count of the injectate was performed and recorded by lab staff with a cell counter (TC10; Bio-Rad Laboratories, Hercules, CA, USA).…”
Section: Treatment Protocol Harvest and Bone Marrow Concentrationmentioning
confidence: 99%